Home › Coronary Artery Disease › Louisiana
Coronary Artery Disease clinical trials in Louisiana
4 studies for Coronary Artery Disease are looking for participants at sites in Louisiana.
Cities in Louisiana
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Grace Research, LLC, Bossier City
- Louisiana Heart Center, Covington
- Tulane School of Medicine, New Orleans
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06909565Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Renal Associates of Baton Rouge, Baton Rouge
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Product Surveillance Registry
- New Orleans
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Tulane University Heart and Vascular Institute, New Orleans
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT02061436From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.